Yan Chang Selected Research

Bile Acids and Salts (Bile Acids)

1/2022

A human Barrett's esophagus organoid system reveals epithelial-mesenchymal plasticity induced by acid and bile salts.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Yan Chang Research Topics

Disease

26	Neoplasms (Cancer) 02/2024 - 04/2002
23	Experimental Arthritis 01/2023 - 02/2007
20	Arthritis (Polyarthritis) 07/2022 - 01/2011
18	Rheumatoid Arthritis 01/2024 - 09/2010
10	Inflammation (Inflammations) 03/2024 - 01/2013
10	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 01/2022 - 03/2001
9	Leukemia 01/2018 - 03/2001
8	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 07/2006 - 06/2000
5	Chronic Obstructive Pulmonary Disease (COPD) 11/2023 - 01/2013
4	Autoimmune Diseases (Autoimmune Disease) 01/2024 - 01/2011
4	Melanoma (Melanoma, Malignant) 03/2023 - 07/2008
4	Infections 01/2023 - 06/2009
4	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 10/2011 - 03/2001
3	Alzheimer Disease (Alzheimer's Disease) 12/2023 - 01/2020
3	Carcinogenesis 11/2022 - 04/2020
3	Esophageal Neoplasms (Esophageal Cancer) 02/2022 - 01/2018
3	Hypoxia (Hypoxemia) 10/2016 - 06/2009
3	Residual Neoplasm 08/2012 - 11/2005
2	Neuroblastoma 01/2024 - 07/2023
2	Cognitive Dysfunction 12/2023 - 01/2020
2	Disease Progression 12/2023 - 01/2021
2	Esophageal Squamous Cell Carcinoma 01/2023 - 02/2022
2	Osteoarthritis 01/2023 - 01/2023
2	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 10/2022 - 12/2019
2	Coronary Disease (Coronary Heart Disease) 08/2022 - 07/2022
2	Prostatic Neoplasms (Prostate Cancer) 01/2021 - 12/2019
2	Squamous Cell Carcinoma (Epidermoid Carcinoma) 04/2020 - 01/2018
2	Testicular Neoplasms (Testicular Cancer) 01/2020 - 12/2017
2	Necrosis 02/2019 - 12/2013
2	Multiple Myeloma 12/2017 - 09/2005
2	Breast Neoplasms (Breast Cancer) 04/2016 - 01/2002
2	Systemic Lupus Erythematosus (Libman-Sacks Disease) 01/2016 - 10/2015
2	Allergic Contact Dermatitis 02/2015 - 12/2013
2	Hepatocellular Carcinoma (Hepatoma) 05/2012 - 07/2010

Drug/Important Bio-Agent (IBA)

15	Proteins (Proteins, Gene)FDA Link 01/2023 - 02/2002
9	Therapeutic UsesIBA 04/2023 - 05/2011
8	Messenger RNA (mRNA)IBA 01/2023 - 06/2001
7	Immunoglobulin D (IgD)IBA 02/2022 - 01/2016
6	AntigensIBA 01/2020 - 02/2002
6	peoniflorinIBA 08/2019 - 10/2011
6	GlucosidesIBA 08/2016 - 02/2007
5	Long Noncoding RNAIBA 01/2024 - 04/2020
5	Methotrexate (Mexate)FDA LinkGeneric 01/2023 - 05/2013
5	CalciumIBA 02/2022 - 01/2016
5	B-Cell Activating FactorIBA 06/2019 - 05/2011
5	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 12/2013 - 09/2001
4	Amyloid (Amyloid Fibrils)IBA 12/2023 - 01/2020
4	LigandsIBA 01/2023 - 05/2011
4	paeoniflorin-6'-O-benzenesulfonateIBA 07/2022 - 01/2016
4	Immunoglobulin G (IgG)IBA 10/2021 - 05/2011
4	CytokinesIBA 01/2021 - 12/2013
4	Monoclonal AntibodiesIBA 04/2016 - 10/2002
4	AntibodiesIBA 05/2012 - 10/2002
3	Interleukin-10 (Interleukin 10)IBA 03/2024 - 12/2013
3	Interleukin-4 (Interleukin 4)IBA 03/2024 - 12/2013
3	Doxorubicin (Adriamycin)FDA LinkGeneric 02/2024 - 09/2005
3	Biomarkers (Surrogate Marker)IBA 11/2023 - 10/2011
3	RNA (Ribonucleic Acid)IBA 03/2023 - 01/2021
3	DNA (Deoxyribonucleic Acid)IBA 01/2023 - 01/2020
3	Interleukin-17 (Interleukin 17)IBA 02/2022 - 12/2013
3	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 10/2021 - 09/2010
3	G-Protein-Coupled Receptor Kinase 2IBA 12/2019 - 02/2019
3	Dinoprostone (PGE2)FDA Link 12/2019 - 11/2014
3	Telomerase (Telomerase Reverse Transcriptase)IBA 10/2016 - 06/2009
3	20- O- (beta- D- glucopyranosyl)- 20(S)- protopanaxadiolIBA 07/2016 - 10/2014
3	TACI receptor-IgG Fc fragment fusion proteinIBA 05/2013 - 05/2011
2	Hemoglobins (Hemoglobin)IBA 04/2024 - 02/2007
2	Cisplatin (Platino)FDA LinkGeneric 01/2024 - 03/2023
2	Antineoplastic Agents (Antineoplastics)IBA 03/2023 - 02/2022
2	Tryptophan (L-Tryptophan)FDA Link 01/2023 - 01/2022
2	Aryl Hydrocarbon Receptors (Aryl Hydrocarbon Receptor)IBA 01/2023 - 07/2022
2	Epirubicin (Ellence)FDA LinkGeneric 01/2023 - 01/2018
2	KynurenineIBA 01/2023 - 01/2022
2	CreatinineIBA 11/2022 - 01/2013
2	U3 small nucleolar RNAIBA 11/2022 - 11/2021
2	Carrier Proteins (Binding Protein)IBA 11/2022 - 11/2021
2	Oxygen (Dioxygen)IBA 08/2022 - 07/2022
2	RP4010IBA 02/2022 - 01/2018
2	Peptides (Polypeptides)IBA 01/2020 - 01/2018
2	Cell Surface ReceptorsIBA 01/2020 - 12/2019
2	immunoglobulin D receptorIBA 12/2019 - 01/2016
2	ProstaglandinsIBA 08/2019 - 05/2012
2	Immunoglobulins (Immunoglobulin)IBA 06/2019 - 11/2017
2	Immunoglobulin A (IgA)IBA 01/2019 - 05/2012
2	NF-kappa B (NF-kB)IBA 01/2018 - 09/2005
2	IntegrinsIBA 01/2018 - 06/2000
2	Bortezomib (Velcade)FDA Link 12/2017 - 09/2005
2	Indicators and Reagents (Reagents)IBA 04/2016 - 07/2010
2	Caspase 3 (Caspase-3)IBA 08/2015 - 09/2005
2	Freund's AdjuvantIBA 03/2015 - 02/2015
2	Interleukin-2 (IL2)IBA 02/2015 - 12/2013
2	OzoneIBA 01/2015 - 01/2013
2	NucleophosminIBA 07/2013 - 02/2009

Therapy/Procedure

21	Therapeutics 02/2024 - 09/2005
9	Drug Therapy (Chemotherapy) 01/2024 - 06/2001
2	Intra-Articular Injections 01/2023 - 12/2013
2	Activities of Daily Living (ADL) 08/2022 - 08/2022
2	Immunotherapy 01/2020 - 04/2016
2	Intradermal Injections 03/2015 - 02/2015
2	Oral Administration 02/2015 - 05/2010